Senti Biosciences enters merger agreement with Celadon Partners SPV 35
The company executed a definitive agreement and plan of merger with Celadon Partners SPV 35 Limited, along with specified affiliates, defining terms for a corporate restructuring effective in July 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day